Entity usage

Jump to navigation Jump to search

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

List of pages that use a given entity

Showing below up to 50 results in range #101 to #150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Kerr BA, et al. Oncotarget (2015) cited as Ref 672 in DOI: 10.1038/s41392-020-0110-5: Title
  2. Deng Zhenling, et al. BMC Immunology (2015) cited as Ref 671 in DOI: 10.1038/s41392-020-0110-5: Title
  3. Vassilopoulos A, et al. Oncogene (2014) cited as Ref 670 in DOI: 10.1038/s41392-020-0110-5: Title
  4. Baumann P, et al. Cancer Res. (2005) cited as Ref 669 in DOI: 10.1038/s41392-020-0110-5: Title
  5. Yin AH, et al. Blood (1997) cited as Ref 668 in DOI: 10.1038/s41392-020-0110-5: Title
  6. Kumar A, et al. Tumour Biol. (2016) cited as Ref 667 in DOI: 10.1038/s41392-020-0110-5: Title
  7. Azevedo R, et al. Clin. Proteom. (2018) cited as Ref 666 in DOI: 10.1038/s41392-020-0110-5: Title
  8. Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5: Title
  9. Wright MH, et al. Breast Cancer Res. (2008) cited as Ref 664 in DOI: 10.1038/s41392-020-0110-5: Title
  10. Fillmore CM, et al. Breast Cancer Res. (2008) cited as Ref 663 in DOI: 10.1038/s41392-020-0110-5: Title
  11. Ricardo S, et al. J. Clin. Pathol. (2011) cited as Ref 662 in DOI: 10.1038/s41392-020-0110-5: Title
  12. Liu TJ, et al. Oncogene (2013) cited as Ref 661 in DOI: 10.1038/s41392-020-0110-5: Title
  13. Lu HH, et al. Nat. Cell Biol. (2014) cited as Ref 660 in DOI: 10.1038/s41392-020-0110-5: Title
  14. Pece S, et al. Cell (2010) cited as Ref 659 in DOI: 10.1038/s41392-020-0110-5: Title
  15. Shackleton M, et al. Nature (2006) cited as Ref 658 in DOI: 10.1038/s41392-020-0110-5: Title
  16. Moselhy J, et al. Anticancer Res. (2015) cited as Ref 657 in DOI: 10.1038/s41392-020-0110-5: Title
  17. Du F-Y, et al. World J. Stem Cells (2019) cited as Ref 656 in DOI: 10.1038/s41392-020-0110-5: Title
  18. Sancho P, et al. Br. J. Cancer (2016) cited as Ref 655 in DOI: 10.1038/s41392-020-0110-5: Title
  19. Wainwright EN, et al. Trends Cancer (2017) cited as Ref 654 in DOI: 10.1038/s41392-020-0110-5: Title
  20. Jiang Q, et al. Nat. Rev. Cancer (2017) cited as Ref 653 in DOI: 10.1038/s41392-020-0110-5: Title
  21. Takeishi S, et al. Cancer Sci. (2016) cited as Ref 652 in DOI: 10.1038/s41392-020-0110-5: Title
  22. Plaks V, et al. Cell Stem Cell (2015) cited as Ref 651 in DOI: 10.1038/s41392-020-0110-5: Title
  23. Shultz LD, et al. Nat. Rev. Immunol. (2012) cited as Ref 650 in DOI: 10.1038/s41392-020-0110-5: Title
  24. Bao B, et al. Current protocols in pharmacology Chapter 14:Unit14.25 (2013) cited as Ref 649 in DOI: 10.1038/s41392-020-0110-5: Title
  25. Liu B, et al. Am. J. Cancer Res. (2019) cited as Ref 648 in DOI: 10.1038/s41392-020-0110-5: Title
  26. Chang L, et al. Oncotarget (2016) cited as Ref 647 in DOI: 10.1038/s41392-020-0110-5: Title
  27. Zhao J, et al. Pharmacol. Ther. (2016) cited as Ref 646 in DOI: 10.1038/s41392-020-0110-5: Title
  28. Prieto-Vila M, et al. Int. J. Mol. Sci. (2017) cited as Ref 645 in DOI: 10.1038/s41392-020-0110-5: Title
  29. Rich JN, et al. Medicine (2016) cited as Ref 644 in DOI: 10.1038/s41392-020-0110-5: Title
  30. Nandy SB, et al. Prog. Mol. Biol. Transl. Sci. (2017) cited as Ref 643 in DOI: 10.1038/s41392-020-0110-5: Title
  31. Hodi FS, et al. N. Engl. J. Med. (2010) cited as Ref 642 in DOI: 10.1038/s41392-020-0110-5: Title
  32. Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5: Title
  33. Fujiwara Y, et al. Cancer Sci. (2019) cited as Ref 640 in DOI: 10.1038/s41392-020-0110-5: Title
  34. Motzer RJ, et al. N. Engl. J. Med. (2019) cited as Ref 639 in DOI: 10.1038/s41392-020-0110-5: Title
  35. Migden MR, et al. N. Engl. J. Med. (2018) cited as Ref 638 in DOI: 10.1038/s41392-020-0110-5: Title
  36. Cortese I, et al. N. Engl. J. Med. (2019) cited as Ref 637 in DOI: 10.1038/s41392-020-0110-5: Title
  37. Meindl-Beinker NM, et al. BMC Cancer (2019) cited as Ref 636 in DOI: 10.1038/s41392-020-0110-5: Title
  38. Sakamuri D, et al. Mol. Cancer Ther. (2018) cited as Ref 635 in DOI: 10.1038/s41392-020-0110-5: Title
  39. Salgia R, et al. Lung Cancer (2017) cited as Ref 634 in DOI: 10.1038/s41392-020-0110-5: Title
  40. Hainsworth JD, et al. Target Oncol. (2016) cited as Ref 633 in DOI: 10.1038/s41392-020-0110-5: Title
  41. Galsky MD, et al. Clin. Cancer Res. (2014) cited as Ref 632 in DOI: 10.1038/s41392-020-0110-5: Title
  42. Cooper TM, et al. Pediatr. Blood Cancer (2017) cited as Ref 631 in DOI: 10.1038/s41392-020-0110-5: Title
  43. Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5: Title
  44. Cashen A, et al. Biol. Blood Marrow Transplant. (2008) cited as Ref 629 in DOI: 10.1038/s41392-020-0110-5: Title
  45. Saygin C, et al. Cell Stem Cell (2019) cited as Ref 628 in DOI: 10.1038/s41392-020-0110-5: Title
  46. Konopleva M, et al. Cancer Discov. (2016) cited as Ref 627 in DOI: 10.1038/s41392-020-0110-5: Title
  47. Cortes JE, et al. J. Clin. Oncol. (2015) cited as Ref 626 in DOI: 10.1038/s41392-020-0110-5: Title
  48. Jimeno A, et al. Clin. Cancer Res. (2013) cited as Ref 625 in DOI: 10.1038/s41392-020-0110-5: Title
  49. Le PN, et al. Pharmacol. Ther. (2015) cited as Ref 624 in DOI: 10.1038/s41392-020-0110-5: Title
  50. Lin W, et al. Biomed. Res. Int. (2019) cited as Ref 623 in DOI: 10.1038/s41392-020-0110-5: Title

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)